Table 2:
Univariate analysis | Multivariate analysis | |||
---|---|---|---|---|
Characteristic | HR (95% CI) | P-value | HR 95% CI | P-value |
Histology | 0.94 (0.70 – 1.27) | 0.694 | ||
Immunotherapy exposure | 1.03 (0.75 – 1.43) | 0.845 | ||
Visceral metastasis | 1.66 (1.27 – 2.19) | < 0.001 | 1.48 (1.16 – 1.91) | 0.002 |
CNS metastasis | 1.33 (1.00 – 1.79) | 0.053 | ||
RECIST SLD | 1.05 (1.03 – 1.08) | < 0.0001 | ||
CT volume | 1.00 (1.00 – 1.00) | < 0.0001 | 1.00 (1.00 – 1.00) | < 0.001 |
TP53+ | 1.58 (1.25 – 2.00) | < 0.001 | 1.45 (1.16 – 1.80) | 0.001 |
EGFR+ | 1.19 (0.92 – 1.53) | 0.179 | 1.36 (1.08 – 1.71) | 0.009 |
KRAS+ | 1.22 (0.91 – 1.64) | 0.178 |